APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 21 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $62,000 | +14.8% | 41,000 | -6.8% | 0.00% | 0.0% |
Q3 2021 | $54,000 | -73.1% | 44,000 | -59.6% | 0.00% | -66.7% |
Q2 2021 | $201,000 | +68.9% | 109,000 | +28.2% | 0.00% | +50.0% |
Q1 2021 | $119,000 | -13.8% | 85,000 | +3.7% | 0.00% | 0.0% |
Q4 2020 | $138,000 | – | 82,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 39,528,000 | $49,938,921 | 2.17% |
LINDEN ADVISORS LP | 15,000,000 | $18,816,676 | 0.19% |
Verition Fund Management LLC | 12,454 | $15,645,338 | 0.18% |
WOLVERINE ASSET MANAGEMENT LLC | 11,766,000 | $14,863,606 | 0.17% |
PALISADE CAPITAL MANAGEMENT, LP | 1,017,000 | $1,284,573 | 0.04% |
LAZARD ASSET MANAGEMENT LLC | 12,242,000 | $15,379 | 0.02% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 300,000 | $371,070 | 0.01% |
D. E. Shaw & Co., Inc. | 5,000,000 | $6,267,238 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
CITIGROUP INC | 504,000 | $623,398 | 0.00% |